REPORT ID 6689

Asia-Pacific Tumor Ablation Market Report 2017

Publish Date
26-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the Asia-Pacific Tumor Ablation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Tumor Ablation for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Tumor Ablation market competition by top manufacturers/players, with Tumor Ablation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Angiodynamics
    Medtronic
    Boston Scientific
    Galil Medical
    Neuwave Medical
    Misonix
    Merit Medical
    Sonacare Medical
    EDAP TMS

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Radiofrequency (RF) Ablation
    Microwave Ablation
    Cryoablation
    Other Technologies

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Tumor Ablation for each application, includin
    Liver Cancer
    Lung Cancer
    Kidney Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Tumor Ablation Market Report 2017
1 Tumor Ablation Overview
    1.1 Product Overview and Scope of Tumor Ablation
    1.2 Classification of Tumor Ablation by Product Category
        1.2.1 Asia-Pacific Tumor Ablation Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Tumor Ablation Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Radiofrequency (RF) Ablation
        1.2.4 Microwave Ablation
        1.2.5 Cryoablation
        1.2.6 Other Technologies
    1.3 Asia-Pacific Tumor Ablation Market by Application/End Users
        1.3.1 Asia-Pacific Tumor Ablation Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Liver Cancer
        1.3.3 Lung Cancer
        1.3.4 Kidney Cancer
        1.3.5 Others
    1.4 Asia-Pacific Tumor Ablation Market by Region
        1.4.1 Asia-Pacific Tumor Ablation Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Tumor Ablation (2012-2022)
        1.5.1 Asia-Pacific Tumor Ablation Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Tumor Ablation Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Tumor Ablation Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Tumor Ablation Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Tumor Ablation Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Tumor Ablation Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Tumor Ablation (Volume and Value) by Type
        2.2.1 Asia-Pacific Tumor Ablation Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Tumor Ablation Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Tumor Ablation (Volume) by Application
    2.4 Asia-Pacific Tumor Ablation (Volume and Value) by Region
        2.4.1 Asia-Pacific Tumor Ablation Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Tumor Ablation Revenue and Market Share by Region (2012-2017)

3 China Tumor Ablation (Volume, Value and Sales Price)
    3.1 China Tumor Ablation Sales and Value (2012-2017)
        3.1.1 China Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Tumor Ablation Revenue and Growth Rate (2012-2017)
        3.1.3 China Tumor Ablation Sales Price Trend (2012-2017)
    3.2 China Tumor Ablation Sales Volume and Market Share by Type
    3.3 China Tumor Ablation Sales Volume and Market Share by Application

4 Japan Tumor Ablation (Volume, Value and Sales Price)
    4.1 Japan Tumor Ablation Sales and Value (2012-2017)
        4.1.1 Japan Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Tumor Ablation Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Tumor Ablation Sales Price Trend (2012-2017)
    4.2 Japan Tumor Ablation Sales Volume and Market Share by Type
    4.3 Japan Tumor Ablation Sales Volume and Market Share by Application

5 South Korea Tumor Ablation (Volume, Value and Sales Price)
    5.1 South Korea Tumor Ablation Sales and Value (2012-2017)
        5.1.1 South Korea Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Tumor Ablation Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Tumor Ablation Sales Price Trend (2012-2017)
    5.2 South Korea Tumor Ablation Sales Volume and Market Share by Type
    5.3 South Korea Tumor Ablation Sales Volume and Market Share by Application

6 Taiwan Tumor Ablation (Volume, Value and Sales Price)
    6.1 Taiwan Tumor Ablation Sales and Value (2012-2017)
        6.1.1 Taiwan Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Tumor Ablation Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Tumor Ablation Sales Price Trend (2012-2017)
    6.2 Taiwan Tumor Ablation Sales Volume and Market Share by Type
    6.3 Taiwan Tumor Ablation Sales Volume and Market Share by Application

7 India Tumor Ablation (Volume, Value and Sales Price)
    7.1 India Tumor Ablation Sales and Value (2012-2017)
        7.1.1 India Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Tumor Ablation Revenue and Growth Rate (2012-2017)
        7.1.3 India Tumor Ablation Sales Price Trend (2012-2017)
    7.2 India Tumor Ablation Sales Volume and Market Share by Type
    7.3 India Tumor Ablation Sales Volume and Market Share by Application

8 Southeast Asia Tumor Ablation (Volume, Value and Sales Price)
    8.1 Southeast Asia Tumor Ablation Sales and Value (2012-2017)
        8.1.1 Southeast Asia Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Tumor Ablation Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Tumor Ablation Sales Price Trend (2012-2017)
    8.2 Southeast Asia Tumor Ablation Sales Volume and Market Share by Type
    8.3 Southeast Asia Tumor Ablation Sales Volume and Market Share by Application

9 Australia Tumor Ablation (Volume, Value and Sales Price)
    9.1 Australia Tumor Ablation Sales and Value (2012-2017)
        9.1.1 Australia Tumor Ablation Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Tumor Ablation Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Tumor Ablation Sales Price Trend (2012-2017)
    9.2 Australia Tumor Ablation Sales Volume and Market Share by Type
    9.3 Australia Tumor Ablation Sales Volume and Market Share by Application

10 Asia-Pacific Tumor Ablation Players/Suppliers Profiles and Sales Data
    10.1 Angiodynamics
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Tumor Ablation Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Angiodynamics Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Medtronic
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Tumor Ablation Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Medtronic Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Boston Scientific
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Tumor Ablation Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Boston Scientific Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Galil Medical
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Tumor Ablation Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Galil Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Neuwave Medical
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Tumor Ablation Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Neuwave Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Misonix
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Tumor Ablation Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Misonix Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Merit Medical
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Tumor Ablation Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Merit Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Sonacare Medical
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Tumor Ablation Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Sonacare Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 EDAP TMS
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Tumor Ablation Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 EDAP TMS Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview

11 Tumor Ablation Manufacturing Cost Analysis
    11.1 Tumor Ablation Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Tumor Ablation

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Tumor Ablation Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Tumor Ablation Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Tumor Ablation Market Forecast (2017-2022)
    15.1 Asia-Pacific Tumor Ablation Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Tumor Ablation Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Tumor Ablation Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Tumor Ablation Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Tumor Ablation Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Tumor Ablation Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Tumor Ablation Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Tumor Ablation Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Tumor Ablation Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Tumor Ablation Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Tumor Ablation Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Tumor Ablation Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Tumor Ablation Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer